SHANA HOLMAN: Open Payments
NPI 1184214306 · GALESBURG, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$380 in 19 payments from 8 companies in 2025. Trend: 2023 $325 · 2024 $333 · 2025 $380
Food & beverage: $380
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $181 |
| ABBVIE INC. | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Novo Nordisk Inc | 2 | $33 |
| Almatica Pharma LLC | 1 | $22 |
| Amgen Inc. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
Products named: VRAYLAR, FARXIGA, ABILIFY MAINTENA, UBRELVY, AIRSUPRA, LOREEV XR, EVENITY, Ozempic.
Industry payments across IL — which companies pay providers there.
